CONJUGATED LINOLEIC ACID TG 60% POWDER

Conjugated Linoleic Acid (CLA) is a naturally occurring fatty acid, a derivative of the essential omega-6 fatty acid, linoleic acid. Primarily found in the meat and dairy products of ruminant animals, CLA is not synthesized by the human body and must be obtained through diet or supplementation. The term "conjugated" refers to the unique arrangement of its double bonds, which differentiates it from other fatty acids and is responsible for its distinct biological activities. This CONJUGATED LINOLEIC ACID TG 60% POWDER is a high-quality, standardized ingredient, delivering 60% active CLA in a stable triglyceride (TG) form, presented as a versatile powder. This ensures ease of formulation and superior bioavailability compared to free fatty acid forms, making it an excellent choice for a wide range of dietary supplements.

CLA's health benefits are largely attributed to its specific isomers, primarily cis-9, trans-11 (c9,t11) and trans-10, cis-12 (t10,c12), which exhibit distinct biological mechanisms. Extensive research has focused on CLA's role in body composition, with studies suggesting its potential to reduce body fat mass and increase lean muscle mass. The t10,c12 isomer, in particular, has been implicated in inhibiting lipoprotein lipase activity, an enzyme crucial for fat storage, and enhancing fat oxidation. Furthermore, CLA has been investigated for its metabolic support properties, including its potential to modulate glucose metabolism and improve insulin sensitivity in certain populations. Its anti-inflammatory effects, mediated by influencing eicosanoid pathways and cytokine production, also contribute to its broad spectrum of potential health benefits.

This CLA TG 60% Powder is a highly sought-after ingredient in formulations targeting weight management, sports nutrition, and overall metabolic health. Its powdered format offers exceptional versatility for incorporation into various delivery systems, including capsules, tablets, functional food blends, and protein powders, ensuring precise dosing and excellent stability. Quality considerations are paramount, with emphasis on the purity, precise isomer profile, and consistent concentration of active CLA to ensure efficacy. Clinical trials, such as a meta-analysis published in the American Journal of Clinical Nutrition, have demonstrated a modest but significant reduction in body fat mass with CLA supplementation, reinforcing its evidence-based application. Ongoing research continues to refine our understanding of optimal dosages and specific isomer ratios for targeted health outcomes, solidifying CLA's position as a valuable nutraceutical ingredient.